Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

3.570 -0.160 (-4.29%)
Delayed Quote Updated: 10:35 AM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,702
Open 3.670
Bid (Size) 3.520 (100)
Ask (Size) 3.710 (100)
Prev. Close 3.730
Today's Range 3.530 - 3.690
52wk Range 3.230 - 80.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
From bioAffinity Technologies, Inc.
Via Business Wire

Performance

52-Week Range 95.6% below 52-week high
3.570
3.2352W Low 80.7052W High
1 Week 24.8% below 1-week high
3.231W Low 4.751W High

bioAffinity Technologies, Inc. - Common Stock (BIAF) traded between $3.23 and $80.70 over the past 52 weeks and last traded at $3.57, 95.6% below its 52-week high. Over the past week it ranged between $3.23 and $4.75.

Past 12 Months
-8.5%
-62.1%
-65.9%
-91.2%
-80.5%
-91.7%
1W -$0.33
1M -$5.86
3M -$6.91
6M -$36.78
YTD -$14.73
1Y -$39.63

BIAF was -91.7% over the past year, -91.2% over six months, -80.5% year to date, -8.5% in the last week.

12 Months vs Market
BIAF
-91.7%
DIA
+11.1%
SPY
+14.4%
QQQ
+17.9%
IWM
+9.3%

Over the past 12 months BIAF returned -91.7% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 0.00× 3-mo avg
Today 14,702 3-mo avg 3.7M
1W
334.8K
1M
2.5M
3M
3.7M
6M
1.9M
YTD
1.4M
1Y
1.1M

BIAF most recently traded 14,702 shares against a 3-month average daily volume of 3.7M.

More News

Read More
News headline image
bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
From bioAffinity Technologies, Inc.
Via Business Wire
Thursday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference
From bioAffinity Technologies, Inc.
Via Business Wire
These stocks are moving in today's after hours session ↗
Via Chartmill
Top movers in Thursday's session ↗
Via Chartmill
Here are the top movers in Thursday's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
Gapping stocks in Wednesday's session ↗
Via Chartmill
Top movers in Wednesday's pre-market session ↗
Via Chartmill
News headline image
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
From bioAffinity Technologies, Inc.
Via Business Wire
Top movers analysis one hour before the close of the markets on 2026-09-08: top gainers and losers in today's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-09-08: top gainers and losers in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
Via Chartmill
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill

Frequently Asked Questions

Is bioAffinity Technologies, Inc. - Common Stock publicly traded?
Yes, bioAffinity Technologies, Inc. - Common Stock is publicly traded.
What exchange does bioAffinity Technologies, Inc. - Common Stock trade on?
bioAffinity Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for bioAffinity Technologies, Inc. - Common Stock?
The ticker symbol for bioAffinity Technologies, Inc. - Common Stock is BIAF on the Nasdaq Stock Market
What is the current price of bioAffinity Technologies, Inc. - Common Stock?
The current price of bioAffinity Technologies, Inc. - Common Stock is 3.570
When was bioAffinity Technologies, Inc. - Common Stock last traded?
The last trade of bioAffinity Technologies, Inc. - Common Stock was at 10/19/26 10:35 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.